Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.

mSphere · 2021 · PMC8386440 · PMID 34232076

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

cholerae O139 and O1 are identical, but that there is no evident cross protection of O1 versus O139 cholera, suggests that even if core-specific antibodies do contribute some degree of protection, they are not clinically highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.